PFE Jun 2024 35.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:20AM EDT. Market open.
Loading interactive chart…
- Motley Fool
Better Growth Stock: AbbVie vs. Pfizer
AbbVie (NYSE: ABBV) and Pfizer (NYSE: PFE) are two of the world's biggest pharmaceutical companies, and the similarities don't end there. The case for AbbVie as a growth stock can't avoid two issues: the decline of Humira, and the stagnation of its oncology portfolio.
- Zacks
Bear of the Day: BioNTech (BNTX)
BNTX is ranked a lowly 5 for a reason. Earnings have peaked, COVID hysteria has subsided, and the technical picture is lagging.
- Zacks
Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know
In the latest trading session, Pfizer (PFE) closed at $40.22, marking a -0.42% move from the previous day.
© 2023 Yahoo. All rights reserved.
